- AI in PV
- AI Implementation
- AI Training
- AI Compliance
- Regional Coverage
- Expertise
- QPPV Services
- Medical Safety
- Aggregate Reports
- Signal and Risk Management
- Audits and Due Diligence
- Training and Consultancy
- Digital Transformation
- Technology
Find out about the latest developments and changes happening at iVigee here.
Audio Recap, Click Here. Gambia updated its Guideline for Clinical Trials in Humans, effective February 26. This change impacts multiple regulatory areas including aggregate safety reports, clinical trials, and post-marketing ICSR reporting. iViReg users received the validated alert on March 3, with full updates reflected in the Gambia Country Profile by March 10.
Sign up to receive free alerts just like these!
iVigee 2023 milestones. We 2019ve had a few!
As 2023 draws to a close, it a good time to review some of iVigee 2019 s key successes and look back over what has been a tremendous year of innovation and growth for us, captured in this post 2019s slideshow.
Landmark EU Regulation points to implications for AI in Pharmacovigilance!
The European Union reached an important milestone on Saturday with its proposed regulation of Artificial Intelligence. The EU AI Act comes after intense discussions with EU Member States and the European Parliament, with approval scheduled in Spring 2024 and the act coming into force in 2026. The importance of this comes from what is known as the 2018Brussels Effect 2019, where European changes may inspire global shifts in AI governance.
Whatever your pharmacovigilance requirements, our world-leading technology platforms and globally experienced operational teams can provide the solution.